Ciro
Casanova Macario
Professeur Associé
Hospital Universitario de Valme
Sevilla, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Valme (19)
2024
-
Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22
2022
-
Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study
Respiratory Research, Vol. 23, Núm. 1
-
Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years
ERJ Open Research, Vol. 8, Núm. 4
2021
-
Prevalence and Determinants of COPD in Spain: EPISCAN II
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 61-69
-
Prevalence and Determinants of COPD in Spain: EPISCAN II
Archivos de bronconeumologia, Vol. 57, Núm. 1, pp. 61-69
2019
-
10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain —A Summary of the EPISCAN II Protocol
Archivos de Bronconeumologia, Vol. 55, Núm. 1, pp. 38-47
2018
-
Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort
Chest, Vol. 154, Núm. 2, pp. 274-285
-
Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease
BMC Medicine, Vol. 16, Núm. 1
2017
-
Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 53, Núm. 10, pp. 574-582
-
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
The European respiratory journal, Vol. 50, Núm. 5
2016
-
Defining the asthma-COPD overlap syndrome in a COPD Cohort
Chest, Vol. 149, Núm. 1, pp. 45-52
-
Prognostic assessment in COPD without lung function: The B-AE-D indices
European Respiratory Journal, Vol. 47, Núm. 6, pp. 1635-1644
2015
-
Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD
Chest, Vol. 148, Núm. 1, pp. 159-168
-
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data
The Lancet Respiratory Medicine, Vol. 3, Núm. 6, pp. 443-450
2014
-
Clinical application of the COPD assessment test: Longitudinal data from the COPD history assessment in Spain (CHAIN) Cohort
Chest, Vol. 146, Núm. 1, pp. 111-122
-
Erratum: New GOLD classification: Longitudinal data on group assignment [Respir Res. 15, (2014) 3, 10.1186/1465-9921-15-3]
Respiratory Research
-
Finding the best thresholds of FEV1and dyspnea to predict 5-year survival in COPD patients: The COCOMICS study
PLoS ONE, Vol. 9, Núm. 2
-
New GOLD classification: Longitudinal data on group assignment
Respiratory Research, Vol. 15, Núm. 1
2013
-
Multicomponent indices to predict survival in COPD: The COCOMICS study
European Respiratory Journal, Vol. 42, Núm. 2, pp. 323-332